JBF Capital’s Checkpoint Therapeutics CKPT Stock Holding History

JBF Capital’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-165,000	Closed	-$667K	–	68
2025 Q1	$667K	Buy	+165,000	New	+$550K	0.13%	38

JBF Capital's CKPT Position: Q2 2025 in Review

JBF Capital sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 165,000 shares — an estimated $667K sold.

JBF Capital first reported a position in CKPT in Q1 2025 and held it in 1 quarter. The position peaked at $667K in Q1 2025. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

JBF Capital reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
JBF Capital sold 165,000 Checkpoint Therapeutics shares in Q2 2025, an estimated $667K.
JBF Capital first reported a position in Checkpoint Therapeutics in Q1 2025 and held it in 1 quarter.
JBF Capital's Checkpoint Therapeutics position peaked at $667K in Q1 2025.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on JBF Capital's 13F filing for Q2 2025, filed 8 Aug 2025.